Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
10/2010
10/26/2010US7820687 inflammatory diseases such as asthma, Alzheimer's disease, atherosclerosis, diabetes, autoimmune diseases, tumor metastasis and myocardial ischemia; improved bioavailability; 2-(2-(diethylamino)-5-(N-isopropylmethylsulfonamido)pyrimidin-4-ylamino)-3-(4-(pyrrolidine-1-carbonyloxy)phenyl)propanoic acid
10/26/2010US7820685 inhibitors of Aurora protein kinases; antiproliferative agents; melanoma, myeloma, leukemia, lymphoma, neuroblastoma, and cancer; N-(4-(4-(3-methyl-1H-pyrazol-5-ylamino)-6-chloropyrimidin-2-ylthio)phenyl)cyclopentanecarboxamide
10/26/2010US7820682 3-{[(3R)-1-(3,5-dimethoxy-4-methylbenzoyl)-5-(2-phenylethyl)-3-pyrrolidinyl]oxy}benzoic acid methyl ester; treatment of urinary system disease; anticarcinogenic agent, antiarthritic agent, treats proliferative disease, inflammation/immune system disease, Sjogren*s syndrome, brain-related disease
10/26/2010US7820675 Benzofuran compounds
10/26/2010US7820673 Urea derivative, process for producing the same, and use
10/26/2010US7820672 3-[5-chloro-6-methyl-2-(4-methyl-piperazin-1-yl)-pyrimidin-4-yl]-4-( 1H-indol-3-yl)-pyrrole-2,5-dione; T lymphocytes, Protein Kinase C (PKC) and glycogen synthase kinase 3 beta (GSK3B) mediated diseases;
10/26/2010US7820660 N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
10/26/2010US7820659 (R)-3-(3,5-Dichloro-4'-morpholin-4-yl-biphenyl-4-ylmethyl)-1-(4,5,6,7-tetrahydro-1H-benzoimidazol-5-yl)-pyrrolidin-2-one for treating diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome
10/26/2010US7820654 such as 1-[2-(3-Chloro-4-methoxy-phenylamino)-6-phenyl-pyrimidin-4-yl]-piperidin-4-ol for treating atherosclerosis, arthritis, restenosis, diabetic nephropathy, or dyslipidemia, or disease states mediated by low expression of Perlecan
10/26/2010US7820647 e.g. 1-[4-chloro-6-(2,2,2-trifluoro-1-methylethylamino)-5-(2,4,6-trifluorophenyl)pyrimidin-2-yl]-pyrrolidin-2-one; controlling phytopathogenic harmful fungi, such as Ascomycetes, Deuteromycetes, Oomycetes and Basidiomycetes; materials, plants, soil, seeds;
10/26/2010US7820646 Anticancer agents; antiproliferative agents; using an substituted aimidazole compound
10/26/2010CA2598725C Fused aromatic compounds having anti-diabetic activity
10/26/2010CA2449192C Novel nitriles useful as reversible inhibitors of cysteine proteases
10/26/2010CA2293436C Imidazolyl-cyclic acetals as tnf inhibitors
10/26/2010CA2192928C Benzoheterocyclic derivatives
10/21/2010WO2010121164A2 1,4-benzodiazepinone compounds and their use in treating cancer
10/21/2010WO2010121046A1 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2
10/21/2010WO2010121036A1 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of ccr2
10/21/2010WO2010121011A1 4-azetidinyl-1-heteroaryl-cyclohexane antagonists of ccr2
10/21/2010WO2010120935A1 Anti-viral compounds
10/21/2010WO2010120910A1 3-(phenoxypyrrolidin-3-yl-methyl)heteroaryl, 3-(phenylpyrrolidin-3-ylmethoxy)heteroaryl, and 3-(heteroarylpyrrolidin-3-ylmethoxy)heteroaryl compounds
10/21/2010WO2010120112A2 Novel compounds of reverse-turn mimetics, method for manufacturing the same and use thereof
10/21/2010WO2010120058A2 Novel cyanine compound for labelling biomolecules, and preparation method thereof
10/21/2010WO2010119879A1 Pyrimidine compound and its use for pest control
10/21/2010WO2010119878A1 Pyrimidine compound and its use for pest control
10/21/2010WO2010119700A1 Novel compound having 3-heteroarylpyrimidin-4-(3h)-one structure and pharmaceutical preparation containing same
10/21/2010WO2010119194A1 Imidazolidine-2,4-dione derivatives and use thereof as a medicament
10/21/2010WO2010119050A1 New rac1 inhibitors as potential pharmacological agents for heart failure treatment
10/21/2010WO2010118992A1 Process for preparation of endothelial receptor antagonist (bosentan)
10/21/2010WO2010118986A1 Fluoro substituted pyrimidine compounds as jak3 inhibitors
10/21/2010WO2010077607A3 Conjugate addition reactions using bifunctional cinchona-alkaloid-based catalysts
10/21/2010WO2010077589A3 Stat3 inhibitors and therapeutic methods using the same
10/21/2010WO2010068761A3 4-amino-4-oxobutanoyl peptide cyclic analogues, inhibitors of viral replication
10/21/2010WO2009126515A8 Compounds and compositions as protein kinase inhibitors
10/21/2010US20100267964 N-heterocyclylphenyl-substituted cyclic ketoenols
10/21/2010US20100267945 Amine derivative having npy y5 receptor antagonistic activity
10/21/2010US20100267937 Cyanine Dye Labelling Reagents
10/21/2010US20100267793 Method of treatment using n3 alkylated benzimidazole derivatives as mek inhibitors
10/21/2010US20100267776 Arylvinylazacycloalkane compounds and methods of preparation and use thereof
10/21/2010US20100267759 INHIBITORS OF Akt ACTIVITY
10/21/2010US20100267755 Pyrimidine derivatives
10/21/2010US20100267754 Integrin expression inhibitor
10/21/2010US20100267743 3-(phenoxypyrrolidin-3-yl-methyl)heteroaryl, 3-(phenylpyrrolidin-3-ylmethoxy)heteroaryl, and 3-(heteroarylpyrrolidin-3-ylmethoxy)heteroaryl compounds
10/21/2010US20100267741 Compounds, Compositions and Methods Comprising Pyrazole Derivatives
10/21/2010US20100267739 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
10/21/2010US20100267729 Fungicidal heterocyclic amines
10/21/2010US20100267722 Novel proline derivatives
10/21/2010US20100267721 Heterocyclic H3 Antagonists
10/21/2010US20100267719 Enhanced Indolinone Based Protein Kinase Inhibitors
10/21/2010US20100267710 N3 alkylated benzimidazole derivatives as mek inhibitors
10/21/2010US20100267708 Glucokinase activators and pharmaceutical compositions containing the same as an active ingredient
10/21/2010US20100267707 Tyrosine Kinase Inhibitors
10/21/2010US20100267706 Compounds, Compositions and Methods Comprising Pyridazine Derivatives
10/21/2010US20100267701 Substituted pyridyl amide compounds as modulators of the histamine h3 receptor
10/21/2010US20100267698 Benzimidazole and Pyridylimidazole Derivatives
10/21/2010US20100267697 Ion channel modulators
10/21/2010US20100267689 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2
10/21/2010US20100267688 4-azetidinyl-1-heteroaryl-cyclohexane antagonists of ccr2
10/21/2010US20100267687 Phenylpyrazole derivatives
10/21/2010US20100267668 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of ccr2
10/21/2010US20100267634 Anti-Viral Compounds
10/21/2010US20100267561 Herbicidal pyridazinone derivatives
10/21/2010US20100267008 Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups
10/21/2010US20100266714 P2x3 receptor antagonists for treatment of pain
10/21/2010US20100266543 Linked dibenzimidazole antivirals
10/21/2010US20100266539 Chemokine receptor antagonist and medical use thereof
10/21/2010US20100266509 Heteroaryl amide analogues as p2x7 antagonists
10/21/2010CA2758934A1 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2
10/21/2010CA2758929A1 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of ccr2
10/21/2010CA2758918A1 4-azetidinyl-1-heteroaryl-cyclohexane antagonists of ccr2
10/21/2010CA2758904A1 Novel compounds of reverse-turn mimetics, method for manufacturing the same and use thereof
10/21/2010CA2758638A1 Imidazolidine-2,4-dione derivatives and use thereof as a medicament
10/21/2010CA2758614A1 Fluoro substituted pyrimidine compounds as jak3 inhibitors
10/21/2010CA2758484A1 Anti-viral compounds
10/21/2010CA2758108A1 Process for preparation of endothelial receptor antagonist (bosentan)
10/20/2010EP2241555A1 New RAC1 inhibitors as potential pharmacological agents for heart failure treatment
10/20/2010EP2240469A2 Substantially pure and a stable crystalline form of bosentan
10/20/2010EP2240468A1 Selective subtype alpha 2 adrenergic agents and methods for use thereof
10/20/2010EP2240458A1 Aryl sulfonamides as effective analgesics
10/20/2010EP2240178A1 Prolyl hydroxylase inhibitors
10/20/2010EP2240174A1 Pharmaceutical compositions comprising n-ý2-(diethylamino)ethyl¨-5-ý(5-fluoro-1,2- dihydro-2-oxo-3h-indol-3-ylidene)methyl¨-2,4-dimethyl-1h-pyrrole-3-carboxamide
10/20/2010EP2240029A1 Compounds for inflammation and immune-related uses
10/20/2010EP2240016A1 Ampk modulators
10/20/2010EP2049491B1 Heteroaryl compounds useful as inhibitors of e1 activating enzymes
10/20/2010EP1984331B1 Pyrrolidine derivatives as erk inhibitors
10/20/2010EP0959075B1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics
10/20/2010CN101868452A Spiropyrrolidines and their use against HCV and HIV infection
10/20/2010CN101863846A Cis fluorine-containing 1,4-benzodiazepine*derivative and preparation method thereof
10/20/2010CN101863824A Synthesis method of chemical compound containing a dihydrogen ferrocenylmethyl-substituted indenes ketone and pyrrole skeleton
10/19/2010US7816539 Melanocortin receptor MC4 modulators; obesity, sexual disorders, anxiolytic agents, analgesics, antidepressants; 6-(aminomethyl)-2-aminobenzimidazole derivatives
10/19/2010US7816534 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/19/2010US7816529 Sodium and calcium channel antagonists; higher potency; fewer side effects to central nervous system
10/19/2010US7816526 Condensed heterocyclic sulfonyl urea compound, a herbicide containing the same, and a method for weed control using the same
10/19/2010US7816520 Such as 1,4-Bis[5,6-(4,4'-dihydroxy)-diphenyl-1,2,4-triazin-3-yl]benzene; cosmetics for human skin, hair
10/19/2010US7816398 Fatty alcohol drug conjugates
10/19/2010US7816363 Inhibitors of histone deacetylase
10/19/2010US7816361 such as 4-(5-Oxo-3-pyrazin-2-yl-2,5-dihydro-pyrazol-1-yl)-N-(1,2,2,6,6-pentamethyl-piperidin-4-yl)-benzamide, used as immunomodulators for the treatment of rheumatoid arthritis, psoriasis, multiple sclerosis and diabetes
10/19/2010US7816360 MTP inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles
10/19/2010US7816357 Regulation of appetite, antiemetics, immunosuppression, analgesia, inflammation, antinocioception, sedation, and intraocular pressure; synergistic; 2-(4-(Trifluoromethyl)benzyl)-7,8-bis(4-chlorophenyl)-6-(methylamino)-[1,2,4]triazolo[4,3-b]pyridazin-3(2H)-one
10/19/2010US7816353 P70S6 kinase modulators and method of use
1 ... 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 ... 626